Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer
Anemia, already common in cancer patients, is often exacerbated by chemotherapy. Cancer patients who are anemic have been shown to have a blunted response for production of endogenous erythropoietin growth factor. This anemia can be corrected with exogenous erythropoietin growth factors, of which th...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Multimed Inc.
2008
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216424/ |